Call order for base period various radiopharmaceuticals
Ended Awarded Last action
- Contract number
- 36C24924N0048
- Awardee
-
Telix Pharmaceuticals US Inc. UEI NMRHMBK4YTH7
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $774,700
Award facts
- Opportunity
-
- 6505--614-24-1-022-0006 - Radiopharmaceutical (Illuccix) Base + Four Option Years Pre-Solicitation · 36C24923Q0459 · Posted Jul 11, 2023
- Contract value 100% obligated
- $774,700.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fishers, IN 46037, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$135,300 | |
| Original award | $910,000 |
About this award
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Telix Pharmaceuticals US Inc., a global commercial-stage biopharmaceutical company that manufactures diagnostic and therapeutic radiopharmaceutical products. The $774,700.00 call order is for the supply of various radiopharmaceuticals, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities during the base period ending September 30, 2024. This order is part of a larger $17.5 million BPA awarded to Telix in 2022 by the VA National Acquisition Center for Illuccix procurement, as well as a separate $4.55 million BPA awarded by VHA VISN 9 for various radiopharmaceuticals. Telix has multiple contract vehicles with the VA, including Federal Supply Schedule 65 I B contracts, to provide radiopharmaceutical products and services to support the VA's healthcare system for veterans. There is no small business set-aside designation associated with this award.
Quick answers
Who was awarded contract 36C24924N0048?
36C24924N0048 was awarded to Telix Pharmaceuticals US Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C24924N0048 worth?
The government has obligated $774,700 on 36C24924N0048.
Is contract 36C24924N0048 an order under another contract?
Yes. 36C24924N0048 is a BPA call under 36F79722D0197-36C24924A0002, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24924N0048 competed?
The extent of competition for 36C24924N0048 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award